Encompass Health Reports Q2 2026 Earnings; Issues Press Release

What Happened

• Encompass Health Corporation announced its financial results for the three and six months ended June 30, 2026 by issuing a press release dated August 5, 2026 (attached as Exhibit 99.1 to the 8-K). The company also provided supplemental materials for its second-quarter 2026 earnings call (Exhibit 99.2) and embedded iXBRL cover-page tags (Exhibit 104). The filing explains the company’s use of “same-store” comparisons for internal performance metrics and how those comparisons treat market consolidation and capacity expansions.

Key Details

• Press release and 8-K filed August 5, 2026 reporting results for the three- and six-month periods ended June 30, 2026.
• Supplemental earnings-call materials provided as Exhibit 99.2; iXBRL cover-page (104) included.
• Same-store comparisons include results from market consolidation transactions and capacity expansions (including satellite/remote hospitals).
• Regulation FD disclosure included: the information in the 8-K is furnished (not “filed”) and is not incorporated by reference into other filings except where expressly stated. The filing is signed by Douglas E. Coltharp, EVP & CFO.

Why It Matters

• This 8-K formally notifies investors that Encompass Health has released its quarterly financial results and supporting materials—key sources for figures on revenue, net income, margins, and operational trends.
• The company’s note on same-store methodology matters because it explains how acquisitions and capacity changes are reflected in comparable-period metrics, which can affect year-over-year growth comparisons.
• Investors should review the attached press release and supplemental exhibits for the specific financial numbers, guidance (if any), and management commentary before making investment decisions.